CB1 Capital
CB1 Capital is an investment manager that specializes in cannabinoid-based wellness solutions, products and therapies. CB1 aims to effect positive change through cannabinoid wellness by addressing a wide range of unmet medical conditions or have commercial use-cases. CB1 believes that the cannabis plant possesses untapped therapeutic potential and aims to disrupt traditional Western medicine. The firm views cannabinoid-based wellness as a nascent industry poised for significant growth, driven by scientific advancements and shifting public perceptions.
ABOUT CB1 CAPITAL
CB1 Capital is a healthcare hedge fund focusing on cannabinoid-based solutions and bio-pharmaceutical applications and therapies.
CB1 Capital Management is the group's investment management business that invests in securities of select companies in the cannabinoid-wellness space. CB1 Capital Advisors is the group's consulting and advisory arm.
CB1 Capital's investment strategy focuses on sectors such as biopharmaceutical applications, industrial hemp, extraction and nutraceuticals, GMP-compliant laboratories, cultivation and dispensaries, cosmetics, pet foods and supplements, consulting and professional services, education and media, and "picks and shovels" businesses that support the cannabis industry.
The firm does not handle the cannabis plant directly but invests in publicly traded companies and select private ventures within this space.